Skin Cancer News & Features
Link with overall, melanoma-specific survival; increase in CRP also linked to disease progression
Treating metastatic melanoma with a combination of radiotherapy and two immunotherapies that target the CTLA4 and PD-1 pathways could produce an optimal response in more patients.
A new way may have been discovered to more accurately predict the patients likely to respond to genomic-based follow-up therapies, by looking at unique protein patterns in patients with melanoma.
Melanoma in some adolescent and adult patients involve many of the same genetic mutations and would likely respond to the same treatment.
Melanoma screening strategies may be more feasible by focusing on high-risk populations.
- Risk of thyroid cancer increases after a breast cancer diagnosis
- Childhood leukemia study reveals disease subtypes and new treatment options
- Counseling cancer patients on effective nutritional practices
- Chemotherapy before breast cancer surgery increases likelihood of breast-preserving procedure
- Effective management of dietary cholesterol may prevent metastasis in patients with prostate cancer
- Prevalence of childhood cancer survivors increasing
- Targeted drug doubles progression-free survival in Hodgkin lymphoma
- Genetically engineered immunotoxin shows early promise for B-cell malignancies
- Scent-trained dog detects thyroid cancer in human urine samples
- Report shows U.S. cancer deaths on the decline
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|